Geriatric Psychiatry in Palo Alto, CA
5 verified geriatric psychiatry doctors in Palo Alto.
Geriatric psychiatrists treat mental health conditions in older adults.
NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.
Dr. Malathy Kuppuswamy, MD
Geriatric Psychiatry
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Jerome Yesavage, MD
Geriatric Psychiatry
CMS Open Payments· $9,513 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$9,513
Total received
3
Transactions
1
Paying companies
Top paying companies
Among the 847 geriatric psychiatry doctors we've analyzed, about 28% received any industry payment (median $209 among those who did). This doctor's total is higher than 97% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US geriatric psychiatry doctors.
Payments to Jerome Yesavage do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Javaid Sheikh, MD
Geriatric Psychiatry
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Richard Almond, MD
Geriatric Psychiatry
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Elvis-Raymond Mukwikwi, MD
Geriatric Psychiatry
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.